Accelerated Recovery Program for Liver Surgery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a special recovery plan can help patients leave the hospital sooner after liver surgery. Participants will follow various recovery methods, with one group possibly going home the same day as the surgery. The trial requires participants to complete 14 questionnaires over a month to track their recovery experiences. It is suitable for those with a specific type of liver tumor that can be treated with minimally invasive surgery and who can remain nearby the hospital after surgery. As an unphased trial, it offers a unique opportunity to contribute to innovative recovery strategies and potentially benefit from cutting-edge care.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this accelerated recovery protocol is safe for liver surgery patients?
Research has shown that enhanced recovery programs, like the one under study, are generally safe and well-tolerated. These programs can reduce hospital stays and improve recovery for liver surgery patients by encouraging early movement, minimizing painkiller use, and promoting a quicker return to normal eating.
One study found that following the program's steps significantly shortened hospital stays. Another study noted that patients who adhered to these steps experienced better short-term outcomes, such as fewer post-surgery complications.
Overall, the safety data for these programs is promising. They have been successfully used in similar surgeries, suggesting they are safe for most people.12345Why are researchers excited about this trial?
Researchers are excited about the Accelerated Recovery Program for liver surgery because it aims to significantly reduce recovery time compared to standard post-operative care. This innovative protocol allows some patients to potentially be discharged on the same day as their minimally invasive surgery, thanks to a focused recovery plan that includes a clear liquid diet, encouragement of independent movement, and minimized opioid use. By integrating telehealth follow-ups and efficient discharge procedures, this approach could enhance patient convenience and reduce hospital stays, which are big wins for both patients and healthcare systems.
What evidence suggests that this trial's treatments could be effective for accelerated recovery after liver surgery?
Research has shown that the Accelerated Recovery Program, also known as Enhanced Recovery After Surgery (ERAS), offers significant benefits for liver surgery patients. In this trial, participants in the Accelerated Recovery Protocol arm will follow a recovery pathway that may allow discharge on the day of surgery. Studies have found that these protocols help patients leave the hospital sooner and recover more quickly. Patients in this program often experience less pain and require fewer painkillers. Additionally, these programs are associated with fewer post-surgery complications. Overall, evidence suggests that an accelerated recovery program can help patients recover faster and more comfortably after minimally invasive liver surgery.12567
Who Is on the Research Team?
Hop Tran Cao, MD
Principal Investigator
M.D. Anderson Cancer Center
Are You a Good Fit for This Trial?
This trial is for adults over 18 without cirrhosis who have a liver tumor that can be removed with minimally invasive surgery. Participants must not have serious heart or lung conditions, should stay close to the medical center post-surgery, and must understand and sign consent.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo minimally invasive liver resection with an accelerated recovery protocol or standard recovery pathway
Post-operative Monitoring
Participants are monitored post-surgery with telehealth visits on post-operative days 1 and 2, and an in-person clinic visit within 14 days of discharge
Follow-up
Participants complete questionnaires over a 30-day period to assess recovery
What Are the Treatments Tested in This Trial?
Interventions
- Questionnaires
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
Intuitive Surgical Inc
Collaborator